CG Oncology, Inc.

Historical 13F Holders

Symbol
CGON
CUSIP
156944100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 156944100 since 12/18/2024, largest first.

Filer % of Class Filed
RTW Investments, LP 13G/A
9.7% 8/14/2026
Event 6/30/2026
Decheng Capital Global Life Sciences Fund IV, L.P. 13G/A
8.4% 2/14/2025
Event 12/31/2024
T. Rowe Price Investment Management, Inc. 13G 8.0% 5/15/2026
Event 3/31/2026
BlackRock, Inc. 13G/A 6.8% 7/27/2026
Event 6/30/2026
Wellington Management Group LLP 13G/A
6.0% 8/13/2026
Event 6/30/2026
Longitude Capital Partners IV, LLC 13D
6.0% 9/18/2025
Event 9/11/2025
Unique Diamond Investments Ltd 13G/A
5.5% 1/28/2025
Event 12/31/2024
FMR LLC 13G
5.1% 8/6/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Foresite Capital Fund V, L.P. 13G/A
4.9% 8/14/2026
Event 6/30/2026
TCG Crossover GP I, LLC 13G/A
4.8% 5/15/2025
Event 3/31/2025
Seven Fleet Capital Management LP 13D/A
2.0% 10/28/2025
Event 10/6/2025
Seven Fleet Partners LP 13D
2.0% 9/18/2025
Event 9/11/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 99 11.4 M $810M
2026 Q2 237 93.8 M $6.66B
2026 Q1 240 88.1 M $5.93B
2025 Q4 201 82.7 M $3.43B
2025 Q3 180 77.6 M $3.13B
2025 Q2 166 75.9 M $1.97B
2025 Q1 145 70.8 M $1.74B
2024 Q4 142 66.2 M $1.90B
2024 Q3 122 52.2 M $1.96B
2024 Q2 113 43.3 M $1.37B
2024 Q1 97 38.8 M $1.70B